Tag Archives: FDA

Gottlieb Set a New Bar – What Happens Now?

The news that Dr. Gottlieb was leaving his post as Commissioner of FDA took everyone by surprise. Perhaps another surprise to many was the skill and judgment he brought to the job when initially he faced many critics due to … Continue reading

Posted in Current Affairs, FDA Image | Tagged , , | Comments Off on Gottlieb Set a New Bar – What Happens Now?

FDA’s Contribution to the Pricing Issue – Generic Activism

As hearings on Capitol Hill these past two months (and in the months to come) have examined the issue of pharmaceutical pricing to inform potential legislation as well as to garner attention, FDA has been addressing the issue in the … Continue reading

Posted in Generic Drugs | Tagged , , | Comments Off on FDA’s Contribution to the Pricing Issue – Generic Activism

Sorting it Out – FDA AdComm Review for 2018

In 2017, the Advisory Committees voted to recommend approval 71.4 percent of the time; in 2018 it was 66.6 percent. Continue reading

Posted in Advisory Committee Prepapartion | Tagged , , , | 1 Comment

Happy New Year – and FDA Statement on Government Shutdown

Happy New Year. On a personal note, I have been on a hiatus or shutdown myself to take time while undertaking a move. With that behind me, I am back at it and will be posting again with intermittent content … Continue reading

Posted in Uncategorized | Tagged | Comments Off on Happy New Year – and FDA Statement on Government Shutdown

HHS Proposes Pricing in DTC

In May the Administration released a plan called “America’s Patients First” , a blueprint to lower drug prices and reduce out-of-pocket costs. One of the items contained in that blueprint was to have the manufacturers of medicines include the list … Continue reading

Posted in DTC Advertising, FDA Policy | Tagged , , , | Comments Off on HHS Proposes Pricing in DTC